Please be advised that AstraZeneca has transferred all rights for LUMOXITI® (moxetumomab pasudotox-tdfk) to Innate Pharma S.A. as of April 1, 2020. For questions or assistance, please call InnateCares, Monday through Friday, 8 am – 8 pm Eastern Time at 1-844-694-6628.
Fill this form out to allow Access 360 to provide assistance for your IMFINZI prescription. Available in English and Spanish. The IMFINZI Enrollment Form must be signed by the patient to utilize Access 360 patient-specific support.
.png "IMFINZI Affordability Brochure")
This brochure explains affordability options for IMFINZI if you are eligible.
